Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Ferrosoferric Oxide | 5 | 2019 | 349 | 1.630 |
Why?
|
Portal Vein | 3 | 2024 | 437 | 0.980 |
Why?
|
Magnetic Resonance Imaging | 24 | 2024 | 36548 | 0.950 |
Why?
|
Tomography, X-Ray Computed | 28 | 2025 | 20700 | 0.890 |
Why?
|
Vascular Diseases | 4 | 2020 | 1161 | 0.860 |
Why?
|
Diagnostic Imaging | 11 | 2024 | 3530 | 0.840 |
Why?
|
Coronary Angiography | 10 | 2023 | 4498 | 0.770 |
Why?
|
Venous Thrombosis | 3 | 2020 | 1321 | 0.770 |
Why?
|
Societies, Medical | 9 | 2024 | 3955 | 0.760 |
Why?
|
Aorta | 6 | 2024 | 2040 | 0.740 |
Why?
|
Magnetic Resonance Angiography | 4 | 2023 | 1429 | 0.700 |
Why?
|
Contrast Media | 15 | 2019 | 5330 | 0.680 |
Why?
|
Vena Cava, Inferior | 2 | 2020 | 463 | 0.650 |
Why?
|
Antiphospholipid Syndrome | 1 | 2020 | 165 | 0.630 |
Why?
|
Pelvic Neoplasms | 2 | 2020 | 248 | 0.630 |
Why?
|
Abdominal Injuries | 1 | 2022 | 362 | 0.630 |
Why?
|
Aortic Aneurysm, Thoracic | 3 | 2022 | 708 | 0.620 |
Why?
|
Mitral Valve Stenosis | 1 | 2020 | 342 | 0.600 |
Why?
|
Intestinal Diseases | 2 | 2022 | 506 | 0.600 |
Why?
|
Ultrasonography, Doppler | 1 | 2020 | 463 | 0.590 |
Why?
|
Coronary Aneurysm | 2 | 2018 | 234 | 0.580 |
Why?
|
Image Enhancement | 3 | 2019 | 2857 | 0.580 |
Why?
|
Infectious Disease Transmission, Patient-to-Professional | 1 | 2020 | 249 | 0.570 |
Why?
|
Coronary Vessel Anomalies | 2 | 2018 | 308 | 0.570 |
Why?
|
Lymphatic Diseases | 3 | 2015 | 317 | 0.570 |
Why?
|
Aortic Aneurysm | 1 | 2022 | 649 | 0.570 |
Why?
|
Plaque, Atherosclerotic | 4 | 2024 | 1529 | 0.550 |
Why?
|
Veins | 1 | 2021 | 769 | 0.550 |
Why?
|
Evidence-Based Medicine | 5 | 2024 | 3690 | 0.540 |
Why?
|
Lymphoma | 3 | 2017 | 1896 | 0.520 |
Why?
|
Pelvis | 4 | 2020 | 737 | 0.510 |
Why?
|
Vascular Malformations | 1 | 2021 | 470 | 0.500 |
Why?
|
Abdominal Neoplasms | 1 | 2017 | 286 | 0.490 |
Why?
|
Radiotherapy, Conformal | 1 | 2018 | 533 | 0.490 |
Why?
|
Aortic Aneurysm, Abdominal | 1 | 2024 | 1249 | 0.460 |
Why?
|
Heart Transplantation | 3 | 2024 | 3307 | 0.460 |
Why?
|
Artifacts | 2 | 2022 | 1896 | 0.450 |
Why?
|
Urinary Reservoirs, Continent | 1 | 2014 | 29 | 0.450 |
Why?
|
Urogenital Surgical Procedures | 1 | 2014 | 34 | 0.450 |
Why?
|
Urinary Diversion | 1 | 2014 | 134 | 0.430 |
Why?
|
Pericardium | 1 | 2018 | 679 | 0.430 |
Why?
|
Adipose Tissue | 2 | 2018 | 3315 | 0.430 |
Why?
|
Male Urogenital Diseases | 1 | 2013 | 48 | 0.420 |
Why?
|
Lymph Nodes | 6 | 2020 | 3456 | 0.420 |
Why?
|
Urogenital Neoplasms | 1 | 2014 | 130 | 0.410 |
Why?
|
Testicular Neoplasms | 3 | 2015 | 800 | 0.410 |
Why?
|
Viscera | 1 | 2013 | 138 | 0.400 |
Why?
|
Infectious Mononucleosis | 1 | 2013 | 133 | 0.400 |
Why?
|
Coronary Artery Disease | 6 | 2025 | 6544 | 0.400 |
Why?
|
Mucocutaneous Lymph Node Syndrome | 1 | 2017 | 538 | 0.390 |
Why?
|
Mitral Valve | 1 | 2020 | 1475 | 0.390 |
Why?
|
Image Interpretation, Computer-Assisted | 3 | 2015 | 3360 | 0.390 |
Why?
|
Kidney Function Tests | 1 | 2014 | 684 | 0.380 |
Why?
|
Digestive System Diseases | 1 | 2013 | 152 | 0.380 |
Why?
|
Diffusion Magnetic Resonance Imaging | 3 | 2018 | 2805 | 0.370 |
Why?
|
Prostatic Neoplasms | 5 | 2020 | 11094 | 0.360 |
Why?
|
Penile Neoplasms | 1 | 2012 | 158 | 0.360 |
Why?
|
Mitral Valve Insufficiency | 1 | 2020 | 1415 | 0.360 |
Why?
|
Humans | 95 | 2025 | 766117 | 0.350 |
Why?
|
Radiology | 1 | 2024 | 2105 | 0.340 |
Why?
|
Occupational Exposure | 1 | 2020 | 1806 | 0.340 |
Why?
|
Thrombosis | 2 | 2021 | 2955 | 0.340 |
Why?
|
Fractional Flow Reserve, Myocardial | 2 | 2024 | 346 | 0.330 |
Why?
|
Pancreatic Neoplasms | 6 | 2022 | 5454 | 0.330 |
Why?
|
Androgen Antagonists | 1 | 2018 | 1411 | 0.330 |
Why?
|
Arrhythmias, Cardiac | 1 | 2019 | 2255 | 0.330 |
Why?
|
Immunoglobulin G | 3 | 2024 | 4556 | 0.310 |
Why?
|
Mass Screening | 1 | 2024 | 5450 | 0.300 |
Why?
|
Internship and Residency | 2 | 2022 | 5946 | 0.300 |
Why?
|
Inflammation | 5 | 2024 | 10860 | 0.300 |
Why?
|
Vasculitis | 2 | 2023 | 528 | 0.290 |
Why?
|
Diffusion Tensor Imaging | 1 | 2018 | 2415 | 0.290 |
Why?
|
Urinary Bladder | 1 | 2014 | 1155 | 0.290 |
Why?
|
Venous Thromboembolism | 1 | 2020 | 1883 | 0.280 |
Why?
|
Coronary Vessels | 6 | 2025 | 3094 | 0.280 |
Why?
|
Heart Ventricles | 1 | 2019 | 3833 | 0.280 |
Why?
|
Health Personnel | 1 | 2020 | 3387 | 0.270 |
Why?
|
Male | 52 | 2025 | 363935 | 0.260 |
Why?
|
Epstein-Barr Virus Infections | 1 | 2013 | 615 | 0.260 |
Why?
|
Prostate | 1 | 2014 | 1758 | 0.260 |
Why?
|
Heart | 3 | 2022 | 4419 | 0.260 |
Why?
|
Blood Coagulation Disorders | 2 | 2021 | 351 | 0.250 |
Why?
|
Collagen | 1 | 2014 | 2617 | 0.250 |
Why?
|
Coronary Stenosis | 2 | 2023 | 798 | 0.240 |
Why?
|
Middle Aged | 39 | 2025 | 223083 | 0.230 |
Why?
|
Positron-Emission Tomography | 3 | 2019 | 6545 | 0.230 |
Why?
|
Gastrointestinal Diseases | 1 | 2013 | 1204 | 0.230 |
Why?
|
Tuberous Sclerosis | 3 | 2022 | 1039 | 0.220 |
Why?
|
Aged | 31 | 2025 | 171219 | 0.220 |
Why?
|
Algorithms | 2 | 2022 | 14066 | 0.210 |
Why?
|
Anterior Wall Myocardial Infarction | 1 | 2023 | 42 | 0.210 |
Why?
|
Takayasu Arteritis | 1 | 2024 | 106 | 0.210 |
Why?
|
Lymphatic Metastasis | 7 | 2020 | 2890 | 0.210 |
Why?
|
Sensitivity and Specificity | 8 | 2019 | 14645 | 0.210 |
Why?
|
Diagnostic Errors | 2 | 2024 | 1276 | 0.200 |
Why?
|
Angiomyolipoma | 2 | 2015 | 189 | 0.200 |
Why?
|
Phlebography | 1 | 2023 | 326 | 0.190 |
Why?
|
Peripheral Arterial Disease | 2 | 2023 | 1306 | 0.190 |
Why?
|
Predictive Value of Tests | 15 | 2024 | 15403 | 0.190 |
Why?
|
Cardiac-Gated Imaging Techniques | 2 | 2019 | 139 | 0.190 |
Why?
|
Neuroendocrine Tumors | 2 | 2022 | 657 | 0.190 |
Why?
|
Neuroectodermal Tumors, Primitive | 1 | 2022 | 135 | 0.180 |
Why?
|
Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis | 1 | 2025 | 238 | 0.180 |
Why?
|
Autoimmune Diseases | 1 | 2013 | 2249 | 0.180 |
Why?
|
Diagnosis, Differential | 8 | 2021 | 12976 | 0.180 |
Why?
|
Female | 42 | 2025 | 396233 | 0.180 |
Why?
|
Arteritis | 1 | 2023 | 160 | 0.180 |
Why?
|
Retrospective Studies | 23 | 2023 | 81565 | 0.180 |
Why?
|
Carcinoma, Renal Cell | 2 | 2015 | 3186 | 0.180 |
Why?
|
Abdomen | 2 | 2019 | 1135 | 0.180 |
Why?
|
Aneurysm, False | 1 | 2023 | 264 | 0.180 |
Why?
|
Biopsy, Needle | 2 | 2018 | 1613 | 0.170 |
Why?
|
Giant Cell Arteritis | 1 | 2024 | 308 | 0.170 |
Why?
|
Upper Extremity Deep Vein Thrombosis | 1 | 2020 | 25 | 0.170 |
Why?
|
Diverticulum | 1 | 2021 | 137 | 0.170 |
Why?
|
Urinary Bladder Neoplasms | 1 | 2012 | 2176 | 0.170 |
Why?
|
Kidney Neoplasms | 3 | 2015 | 4282 | 0.170 |
Why?
|
Adenocarcinoma | 2 | 2014 | 6363 | 0.160 |
Why?
|
Fluorodeoxyglucose F18 | 3 | 2019 | 2029 | 0.160 |
Why?
|
Epigastric Arteries | 2 | 2022 | 93 | 0.160 |
Why?
|
Cardiomyopathies | 2 | 2023 | 2068 | 0.150 |
Why?
|
Kidney | 1 | 2014 | 7072 | 0.150 |
Why?
|
Quinolines | 1 | 2024 | 769 | 0.150 |
Why?
|
Echocardiography | 3 | 2023 | 5041 | 0.150 |
Why?
|
Nitroglycerin | 1 | 2019 | 332 | 0.150 |
Why?
|
Platelet Count | 1 | 2020 | 784 | 0.150 |
Why?
|
Aortic Diseases | 1 | 2024 | 741 | 0.150 |
Why?
|
Necrosis | 1 | 2022 | 1614 | 0.140 |
Why?
|
Extremities | 1 | 2023 | 868 | 0.140 |
Why?
|
Adult | 24 | 2024 | 223139 | 0.140 |
Why?
|
Gastrointestinal Hemorrhage | 1 | 2024 | 1127 | 0.140 |
Why?
|
Atrial Appendage | 1 | 2021 | 284 | 0.140 |
Why?
|
Appendiceal Neoplasms | 1 | 2019 | 155 | 0.140 |
Why?
|
Ischemia | 2 | 2023 | 1904 | 0.140 |
Why?
|
Statistics as Topic | 2 | 2014 | 2351 | 0.130 |
Why?
|
Iopamidol | 2 | 2016 | 188 | 0.130 |
Why?
|
Tomography Scanners, X-Ray Computed | 1 | 2017 | 170 | 0.130 |
Why?
|
Arteries | 2 | 2024 | 1121 | 0.130 |
Why?
|
T-Lymphocyte Subsets | 1 | 2024 | 1814 | 0.130 |
Why?
|
Cardiovascular System | 1 | 2023 | 838 | 0.130 |
Why?
|
Heart Valve Diseases | 1 | 2023 | 1029 | 0.120 |
Why?
|
Reproducibility of Results | 6 | 2019 | 20137 | 0.120 |
Why?
|
Hemoptysis | 1 | 2016 | 152 | 0.120 |
Why?
|
Multiple Pulmonary Nodules | 1 | 2017 | 174 | 0.120 |
Why?
|
Acute Coronary Syndrome | 2 | 2018 | 2185 | 0.120 |
Why?
|
Incidental Findings | 2 | 2017 | 698 | 0.120 |
Why?
|
Vasodilation | 1 | 2019 | 969 | 0.120 |
Why?
|
alpha-Fetoproteins | 1 | 2015 | 227 | 0.120 |
Why?
|
Upper Extremity | 2 | 2020 | 684 | 0.120 |
Why?
|
Vasodilator Agents | 1 | 2019 | 988 | 0.120 |
Why?
|
Blood Coagulation | 1 | 2021 | 1169 | 0.120 |
Why?
|
Blood Vessel Prosthesis Implantation | 2 | 2022 | 1456 | 0.120 |
Why?
|
Hospitals, General | 2 | 2016 | 803 | 0.120 |
Why?
|
Clinical Protocols | 1 | 2020 | 1437 | 0.120 |
Why?
|
Foreign-Body Migration | 1 | 2016 | 219 | 0.120 |
Why?
|
Mammaplasty | 2 | 2022 | 1264 | 0.110 |
Why?
|
Preoperative Care | 2 | 2014 | 2249 | 0.110 |
Why?
|
Metal Nanoparticles | 1 | 2018 | 400 | 0.110 |
Why?
|
Solitary Pulmonary Nodule | 1 | 2017 | 281 | 0.110 |
Why?
|
Ganglia, Sympathetic | 1 | 2014 | 65 | 0.110 |
Why?
|
Metabolic Clearance Rate | 1 | 2014 | 361 | 0.110 |
Why?
|
Pancreaticoduodenectomy | 1 | 2017 | 515 | 0.110 |
Why?
|
Treatment Outcome | 9 | 2023 | 65219 | 0.110 |
Why?
|
Sarcoidosis | 1 | 2019 | 535 | 0.110 |
Why?
|
Pulmonary Embolism | 2 | 2020 | 2596 | 0.110 |
Why?
|
Calcium | 2 | 2023 | 5770 | 0.110 |
Why?
|
Practice Guidelines as Topic | 3 | 2020 | 7424 | 0.110 |
Why?
|
Substance Abuse, Intravenous | 1 | 2018 | 527 | 0.110 |
Why?
|
Lymphomatoid Granulomatosis | 1 | 2013 | 16 | 0.110 |
Why?
|
HIV Infections | 3 | 2024 | 17535 | 0.100 |
Why?
|
Radiography | 1 | 2024 | 6943 | 0.100 |
Why?
|
Abdominal Wall | 1 | 2014 | 166 | 0.100 |
Why?
|
Embolism, Paradoxical | 1 | 2012 | 55 | 0.100 |
Why?
|
Vascular System Injuries | 1 | 2016 | 245 | 0.100 |
Why?
|
Magnetite Nanoparticles | 1 | 2014 | 309 | 0.100 |
Why?
|
Respiratory Tract Diseases | 1 | 2018 | 744 | 0.100 |
Why?
|
Appendicitis | 1 | 2019 | 680 | 0.100 |
Why?
|
Embolism, Air | 1 | 2012 | 111 | 0.100 |
Why?
|
Splenomegaly | 1 | 2013 | 191 | 0.100 |
Why?
|
Macrophages | 2 | 2024 | 5776 | 0.100 |
Why?
|
Radiation Dosage | 2 | 2018 | 1945 | 0.100 |
Why?
|
Musculoskeletal Diseases | 1 | 2018 | 598 | 0.100 |
Why?
|
Gallbladder Diseases | 1 | 2013 | 139 | 0.100 |
Why?
|
Seminoma | 1 | 2013 | 135 | 0.100 |
Why?
|
Diverticulitis, Colonic | 1 | 2013 | 140 | 0.100 |
Why?
|
Tumor Suppressor Proteins | 2 | 2012 | 2795 | 0.090 |
Why?
|
Health Expenditures | 1 | 2024 | 2389 | 0.090 |
Why?
|
Intracranial Embolism | 1 | 2012 | 188 | 0.090 |
Why?
|
Surgical Mesh | 1 | 2014 | 315 | 0.090 |
Why?
|
Hepatitis | 1 | 2013 | 226 | 0.090 |
Why?
|
Aged, 80 and over | 10 | 2021 | 59515 | 0.090 |
Why?
|
Radiopharmaceuticals | 3 | 2019 | 2702 | 0.090 |
Why?
|
Intermittent Claudication | 2 | 2023 | 305 | 0.090 |
Why?
|
Endovascular Procedures | 2 | 2022 | 2218 | 0.090 |
Why?
|
Adrenal Glands | 1 | 2013 | 556 | 0.090 |
Why?
|
Cardiovascular Agents | 1 | 2017 | 848 | 0.090 |
Why?
|
Pacemaker, Artificial | 1 | 2016 | 828 | 0.090 |
Why?
|
Stomach | 1 | 2015 | 702 | 0.090 |
Why?
|
Neoplasms, Germ Cell and Embryonal | 1 | 2015 | 483 | 0.090 |
Why?
|
Myocarditis | 1 | 2018 | 803 | 0.090 |
Why?
|
United States | 9 | 2024 | 72920 | 0.090 |
Why?
|
Peritoneal Neoplasms | 1 | 2016 | 706 | 0.090 |
Why?
|
Constriction, Pathologic | 2 | 2024 | 1102 | 0.090 |
Why?
|
Foramen Ovale, Patent | 1 | 2012 | 209 | 0.080 |
Why?
|
Tissue Distribution | 1 | 2014 | 2271 | 0.080 |
Why?
|
Emergency Service, Hospital | 3 | 2018 | 7871 | 0.080 |
Why?
|
Registries | 4 | 2018 | 8347 | 0.080 |
Why?
|
Vena Cava Filters | 1 | 2012 | 270 | 0.080 |
Why?
|
Radiography, Abdominal | 1 | 2013 | 543 | 0.080 |
Why?
|
Respiration, Artificial | 1 | 2020 | 2727 | 0.080 |
Why?
|
Inpatients | 1 | 2021 | 2566 | 0.080 |
Why?
|
Tachycardia, Ventricular | 1 | 2018 | 1313 | 0.080 |
Why?
|
Hydroxymethylglutaryl-CoA Reductase Inhibitors | 1 | 2024 | 3249 | 0.080 |
Why?
|
C-Reactive Protein | 1 | 2020 | 3853 | 0.080 |
Why?
|
Sex Factors | 2 | 2020 | 10614 | 0.080 |
Why?
|
Prosthesis Implantation | 1 | 2012 | 594 | 0.070 |
Why?
|
Adolescent | 9 | 2024 | 88819 | 0.070 |
Why?
|
Pancreas | 1 | 2015 | 1699 | 0.070 |
Why?
|
Prospective Studies | 6 | 2023 | 54812 | 0.070 |
Why?
|
Gadolinium DTPA | 3 | 2016 | 822 | 0.070 |
Why?
|
Ultrasonography | 1 | 2021 | 5988 | 0.070 |
Why?
|
Cerebral Angiography | 1 | 2012 | 1263 | 0.070 |
Why?
|
Length of Stay | 1 | 2020 | 6490 | 0.070 |
Why?
|
Atherosclerosis | 1 | 2022 | 3418 | 0.070 |
Why?
|
Combined Modality Therapy | 1 | 2018 | 8525 | 0.070 |
Why?
|
Carcinoma, Pancreatic Ductal | 1 | 2017 | 1762 | 0.060 |
Why?
|
Kidney Diseases | 1 | 2016 | 2100 | 0.060 |
Why?
|
Aorta, Thoracic | 2 | 2022 | 1109 | 0.060 |
Why?
|
Cardiovascular Diseases | 2 | 2024 | 15647 | 0.060 |
Why?
|
Myocardium | 1 | 2018 | 4766 | 0.060 |
Why?
|
Colonoscopy | 1 | 2013 | 1408 | 0.060 |
Why?
|
Immunohistochemistry | 1 | 2018 | 11035 | 0.060 |
Why?
|
Neoplasm Staging | 5 | 2020 | 11200 | 0.060 |
Why?
|
Heart Defects, Congenital | 1 | 2021 | 4712 | 0.060 |
Why?
|
Radiography, Interventional | 1 | 2012 | 1128 | 0.060 |
Why?
|
Hemorrhage | 1 | 2016 | 3466 | 0.060 |
Why?
|
Rectal Neoplasms | 1 | 2013 | 1183 | 0.060 |
Why?
|
Young Adult | 7 | 2016 | 59868 | 0.060 |
Why?
|
Pilot Projects | 2 | 2015 | 8724 | 0.060 |
Why?
|
Immunosuppressive Agents | 1 | 2017 | 4213 | 0.060 |
Why?
|
Neoplasm Invasiveness | 1 | 2012 | 3602 | 0.060 |
Why?
|
Neoplasms, Second Primary | 1 | 2012 | 1056 | 0.060 |
Why?
|
Risk Factors | 5 | 2025 | 74857 | 0.050 |
Why?
|
Ultrasonography, Interventional | 1 | 2012 | 1520 | 0.050 |
Why?
|
Colombia | 1 | 2024 | 288 | 0.050 |
Why?
|
Antibodies, Antineutrophil Cytoplasmic | 1 | 2025 | 297 | 0.050 |
Why?
|
Myocardial Infarction | 1 | 2023 | 11509 | 0.050 |
Why?
|
Societies, Scientific | 1 | 2023 | 221 | 0.050 |
Why?
|
Atrial Fibrillation | 1 | 2021 | 5185 | 0.050 |
Why?
|
Image Processing, Computer-Assisted | 1 | 2018 | 8924 | 0.050 |
Why?
|
Boston | 4 | 2016 | 9335 | 0.050 |
Why?
|
Breast Neoplasms | 2 | 2022 | 21074 | 0.050 |
Why?
|
Postoperative Complications | 1 | 2024 | 15808 | 0.050 |
Why?
|
Colonic Neoplasms | 1 | 2013 | 2532 | 0.050 |
Why?
|
Tuberculosis | 1 | 2014 | 2010 | 0.050 |
Why?
|
Lipoproteins, LDL | 1 | 2024 | 642 | 0.040 |
Why?
|
Subclavian Artery | 1 | 2021 | 138 | 0.040 |
Why?
|
Limb Salvage | 1 | 2023 | 488 | 0.040 |
Why?
|
Case-Control Studies | 1 | 2018 | 22228 | 0.040 |
Why?
|
Computer Simulation | 1 | 2014 | 6254 | 0.040 |
Why?
|
Diabetes Mellitus, Type 1 | 1 | 2015 | 3445 | 0.040 |
Why?
|
Tricuspid Valve | 1 | 2023 | 421 | 0.040 |
Why?
|
Infant | 2 | 2024 | 36427 | 0.040 |
Why?
|
Ovarian Neoplasms | 1 | 2016 | 4904 | 0.040 |
Why?
|
Device Removal | 2 | 2016 | 643 | 0.040 |
Why?
|
Administration, Sublingual | 1 | 2019 | 60 | 0.040 |
Why?
|
Transdermal Patch | 1 | 2019 | 51 | 0.040 |
Why?
|
Severity of Illness Index | 1 | 2017 | 15882 | 0.040 |
Why?
|
Tablets | 1 | 2019 | 149 | 0.040 |
Why?
|
Prevalence | 4 | 2018 | 15827 | 0.040 |
Why?
|
Models, Biological | 1 | 2014 | 9445 | 0.040 |
Why?
|
Giant Cells | 1 | 2018 | 187 | 0.040 |
Why?
|
Echocardiography, Doppler, Color | 1 | 2018 | 353 | 0.040 |
Why?
|
Ventricular Dysfunction | 1 | 2018 | 143 | 0.030 |
Why?
|
Angiography | 1 | 2022 | 1589 | 0.030 |
Why?
|
Administration, Cutaneous | 1 | 2019 | 712 | 0.030 |
Why?
|
Reference Values | 2 | 2015 | 4909 | 0.030 |
Why?
|
Equipment Design | 2 | 2016 | 3489 | 0.030 |
Why?
|
Aerosols | 1 | 2019 | 634 | 0.030 |
Why?
|
ROC Curve | 2 | 2015 | 3614 | 0.030 |
Why?
|
Acute Disease | 2 | 2019 | 7237 | 0.030 |
Why?
|
HIV | 1 | 2022 | 1587 | 0.030 |
Why?
|
Electrocardiography | 2 | 2019 | 6409 | 0.030 |
Why?
|
Echocardiography, Transesophageal | 1 | 2021 | 1093 | 0.030 |
Why?
|
Aortography | 1 | 2016 | 423 | 0.030 |
Why?
|
Lower Extremity | 1 | 2022 | 1218 | 0.030 |
Why?
|
Iodine | 1 | 2016 | 285 | 0.030 |
Why?
|
CA-125 Antigen | 1 | 2016 | 282 | 0.030 |
Why?
|
Mastectomy | 1 | 2022 | 1848 | 0.030 |
Why?
|
Phenotype | 1 | 2012 | 16716 | 0.030 |
Why?
|
Academic Medical Centers | 1 | 2024 | 2782 | 0.030 |
Why?
|
Consensus | 1 | 2023 | 3202 | 0.030 |
Why?
|
Organometallic Compounds | 1 | 2016 | 645 | 0.030 |
Why?
|
Pandemics | 2 | 2022 | 8725 | 0.020 |
Why?
|
Gadolinium | 1 | 2016 | 966 | 0.020 |
Why?
|
Radiographic Image Interpretation, Computer-Assisted | 1 | 2018 | 1225 | 0.020 |
Why?
|
Massachusetts | 2 | 2016 | 8882 | 0.020 |
Why?
|
Injections, Intravenous | 1 | 2012 | 1376 | 0.020 |
Why?
|
Prognosis | 2 | 2024 | 29912 | 0.020 |
Why?
|
Causality | 1 | 2016 | 1247 | 0.020 |
Why?
|
Double-Blind Method | 1 | 2024 | 12426 | 0.020 |
Why?
|
Lung Neoplasms | 1 | 2014 | 13483 | 0.020 |
Why?
|
Age Distribution | 1 | 2015 | 2865 | 0.020 |
Why?
|
Chronic Disease | 1 | 2023 | 9354 | 0.020 |
Why?
|
Defibrillators, Implantable | 1 | 2018 | 1497 | 0.020 |
Why?
|
Child | 4 | 2024 | 80573 | 0.020 |
Why?
|
Drug Hypersensitivity | 1 | 2016 | 903 | 0.020 |
Why?
|
Neoplasms | 1 | 2016 | 22344 | 0.020 |
Why?
|
Cardiac Surgical Procedures | 1 | 2022 | 3682 | 0.020 |
Why?
|
Chi-Square Distribution | 1 | 2012 | 3432 | 0.020 |
Why?
|
Prosthesis Design | 1 | 2012 | 2111 | 0.020 |
Why?
|
Recurrence | 1 | 2018 | 8494 | 0.020 |
Why?
|
Feasibility Studies | 1 | 2016 | 5300 | 0.020 |
Why?
|
Follow-Up Studies | 2 | 2017 | 39243 | 0.010 |
Why?
|
Survival Analysis | 1 | 2017 | 10087 | 0.010 |
Why?
|
Risk Assessment | 2 | 2018 | 24276 | 0.010 |
Why?
|
Radiotherapy Planning, Computer-Assisted | 1 | 2013 | 1642 | 0.010 |
Why?
|
Incidence | 2 | 2012 | 21513 | 0.010 |
Why?
|
Germ-Line Mutation | 1 | 2011 | 1885 | 0.010 |
Why?
|
Time Factors | 2 | 2016 | 40108 | 0.010 |
Why?
|
Renal Insufficiency, Chronic | 1 | 2016 | 2306 | 0.010 |
Why?
|
Survival Rate | 1 | 2016 | 12827 | 0.010 |
Why?
|
Regression Analysis | 1 | 2012 | 6324 | 0.010 |
Why?
|
Comorbidity | 1 | 2016 | 10579 | 0.010 |
Why?
|
Neoadjuvant Therapy | 1 | 2013 | 2897 | 0.010 |
Why?
|
Child, Preschool | 1 | 2024 | 42511 | 0.010 |
Why?
|
Disease Progression | 1 | 2016 | 13616 | 0.010 |
Why?
|
Genotype | 1 | 2012 | 13028 | 0.010 |
Why?
|
Longitudinal Studies | 1 | 2012 | 14747 | 0.010 |
Why?
|
Liver | 1 | 2012 | 7559 | 0.010 |
Why?
|
Age Factors | 1 | 2012 | 18386 | 0.010 |
Why?
|
Neoplasm Recurrence, Local | 1 | 2013 | 9378 | 0.010 |
Why?
|
Cohort Studies | 1 | 2015 | 41684 | 0.010 |
Why?
|
Mutation | 1 | 2012 | 30209 | 0.000 |
Why?
|